Source: Transgenic Research. Unidade: FMRP
Subjects: PLANTAS TRANSGÊNICAS, ARTRITE (TRATAMENTO), MYCOBACTERIUM LEPRAE
ABNT
RODRÍGUEZ-NARCISO, César et al. Expression of Mycobacterium leprae HSP65 in tabacco and its effectiveness as an oral treatment in adjuvant-induced arthritis. Transgenic Research, v. 20, n. 2, p. 221-229, 2011Tradução . . Disponível em: https://doi.org/10.1007/s11248-010-9404-7. Acesso em: 24 ago. 2024.APA
Rodríguez-Narciso, C., Pérez-Tapia, M., Rangel-Cano, R. M., Silva, C. L., Meckes-Fisher, M., Salgado-Garciglia, R., et al. (2011). Expression of Mycobacterium leprae HSP65 in tabacco and its effectiveness as an oral treatment in adjuvant-induced arthritis. Transgenic Research, 20( 2), 221-229. doi:10.1007/s11248-010-9404-7NLM
Rodríguez-Narciso C, Pérez-Tapia M, Rangel-Cano RM, Silva CL, Meckes-Fisher M, Salgado-Garciglia R, Estrada-Parra S, López-Gómez R, Estrada-García I. Expression of Mycobacterium leprae HSP65 in tabacco and its effectiveness as an oral treatment in adjuvant-induced arthritis [Internet]. Transgenic Research. 2011 ; 20( 2): 221-229.[citado 2024 ago. 24 ] Available from: https://doi.org/10.1007/s11248-010-9404-7Vancouver
Rodríguez-Narciso C, Pérez-Tapia M, Rangel-Cano RM, Silva CL, Meckes-Fisher M, Salgado-Garciglia R, Estrada-Parra S, López-Gómez R, Estrada-García I. Expression of Mycobacterium leprae HSP65 in tabacco and its effectiveness as an oral treatment in adjuvant-induced arthritis [Internet]. Transgenic Research. 2011 ; 20( 2): 221-229.[citado 2024 ago. 24 ] Available from: https://doi.org/10.1007/s11248-010-9404-7